INTRODUCTION
The envelope of Sendai virus, like that of other paramyxoviruses, contains two surface glycoproteins (Mountcastle et al., 1971; Choppin & Compans, 1975) . The HN glycoprotein has haemagglutinating and neuraminidase activities and is responsible for the adsorption of virus to neuraminic acid-containing receptors on host cells (Tozawa et al., 1973; Scheid & Choppin, 1974) . The F glycoprotein is the mediator of virus-induced haemolysis and cell fusion and is concerned with the penetration of virus into cells (Homma & Ohuchi, 1973; Scheid & Choppin, 1974) . This envelope component becomes biologically active only after proteolytic cleavage of a precursor protein F0 (mol. wt. approx. 65000) to yield a carboxy-terminal fragment F1 (mol. wt. approx. 50000) and an amino-terminal fragment F2 (mol. wt. approx. 15000) (Homma & Ohuchi, 1973; Scheid & Choppin, 1974) ; the two fragments remain disulphide-linked but they undergo a conformational change with exposure of a new hydrophobic region which is probably the amino-terminus of F 1 (Hsu et al., 1981 ; Kohama et al., 1981) . Virus with uncleaved F protein attaches to cells but lacks cell-fusing and haemolytic activities and is non-infective.
Cleavage of the F glycoprotein is accomplished by a protease from the host cell . The presence, possibly in the plasma membrane, of a protease to which the virus is susceptible is a key factor in determining the host range and tissue tropism of paramyxoviruses (Naga! et al., 1976; Scheid & Choppin, 1976; Choppin & Scheid, 1980) . For example, in the embryonated egg, the F protein of Sendai virus is cleaved and the virus undergoes multiple cycles of replication; in most cells in culture, e.g. L (Homma & Ohuchi, 1973) , MDBK (Scheid & Choppin, 1974) and LLC-MK2 cells (Muramatsu & Homma, 1980) , the protein is largely uncleaved, progeny virus particles are predominantly non-infective and infection does not spread. The F protein can be cleaved artificially by exposure of the virus to trypsin and this treatment results in the activation of infectivity (Homma & Ohuchi, 1973; Scheid & Choppin, 1974; Ohuchi & Homma, 1976) . The presence of trypsin may therefore allow multiple cycles of growth in a normally non-permissive cell system (Shibuta et al., 1971 ; Sugita et al., 1974) . These findings suggest that the substrate specificity of the natural proteolytic activator is similar to that of trypsin. However, the activating protease (s) has not yet been isolated and little more is known of its properties.
Recently, Muramatsu & Homma (1980) reported that the infectivity and haemolytic activity G. APPLEYARD AND G. B. DAVIS of Sendal virus grown in LLC-MK2 cells could be increased by treatment of the virus with chicken allantoic fluid and suggested that this effect was due to the presence of the natural virus activator in soluble form. In this paper, we show that amniotic fluid has far greater activating ability than allantoic fluid and describe some properties of the enzyme from this source.
METHODS

Virus.
Sendai virus, obtained originally from Dr K. Cantell (Helsinki, Finland) was grown in the allantoic cavity of 10-day-old fertile hens' eggs. To produce non-infective virus for activation (MK Sendai virus), cultures of LLC-MK2 cells were inoculated with egg-grown virus at an m.o.i, of about 2. After an adsorption period of 1 h, the cultures were washed, an overlay consisting of RPMI 1640 medium plus 0.2~ bovine serum albumin (BSA) was added and incubation was continued at 36 °C for 2 days. The medium was harvested, clarified by centrifugation at 2000g for 10 min and stored at -70 °C.
Plaque assays. Virus infectivity was measured by plaque assay in cultures of MDBK cells in the presence of trypsin. Medium was removed from confluent cell monolayers in 50 mm Petri dishes, the cultures were washed with phosphate-buffered saline (PBS) containing 10~ (v/v) tryptose-phosphate broth (TPB), and 0.1 ml virus suspension diluted in the same solution was allowed to adsorb at room temperature for 1 h. The cells were then overlaid with 0.8 ~ agar in RPMI 1640 medium plus 5 ~ (v/v) TPB and 2 ~tg/ml trypsin. Cultures were stained with neutral red and plaques counted after 5 or 6 days at 36 °C. To assay infective virus in the presence of virus that was non-infective but capable of being activated, trypsin was initially omitted from the overlay medium. After 2 or 3 days, 2-5 ml of a second overlay containing 8 ~tg/ml trypsin was added. Incubation was continued and plaques were counted 6 or 7 days after infection. The rationale of this technique, using a delayed trypsin overlay, is described under Results.
Infectivity activation tests. These measured the ability of amniotic fluid or other material to convert non-infective Sendai virus to the infective form. MK Sendai virus (25 ~tl) was added to test material diluted in 20 mM-Tris HCI pH 7-6 with 0.2~ BSA and 2 mM-CaCI2 or to diluent alone (0-5 ml). After 2 h at 36 °C, the mixtures were titrated for infective virus in cultures of MDBK cells using a delayed trypsin overlay. The virus incubated with diluent was also titrated with an immediate trypsin overlay to measure total potential infectivity, i.e. infective virus plus virus that was capable of being activated.
Haemolysis activation tests. Amniotic fluid or other activator was diluted in twofold steps in a WHO haemagglutination tray, the diluent consisting of 0.25 ml vol. of saline with 2 mM-CaC12 and 20 mM-HEPES buffer pH 7.4. MK Sendai virus, 0.25 ml, was added to each well; this virus had been subjected to two cycles of freezing and thawing, since unfrozen virus caused little haemolysis even if infective . The mixtures were incubated at 36 °C for 3 h, and 0.25 ml vol. of 1% human group O red blood cells in saline were then added. After a further 3 h at 36 °C, the contents of the wells were gently stirred and the unlysed red cells allowed to sediment at room temperature for 1.5 h. The absorbance of the fluid in each well was measured with a Brinkmann PC 600 dipping probe colorimeter using a 545 nm filter and 1 cm light path. The reciprocal of the dilution of activator that resulted in 50~ haemolysis was taken as the 'haemolysis activation titre'.
Polyacrylamide gel electrophoresis. Samples of radioactively labelled virus were dissociated with SDS under reducing conditions and electrophoresed in slab gels using the discontinuous system essentially as described by Laemmli (1970) . Gels were dried under vacuum and exposed to X-ray film for 4 days.
Reagents. Crystallized bovine trypsin (EC 3.4.21.4, A grade) was obtained from Calbiochem-Behring Corp and crystallized thermolysin (EC 3.4.24.4) (Bacillus thermoproteolyticus rokko), crystallized subtilisin (EC 3.4.21.14) (Bacillus subtilis), plasmin (EC 3.4.21.7) (porcine blood) and bromelain (EC 3.4.22.4) (pineapple stem) from Sigma, The inhibitors N-~-p-tosyl-r-lysyl chloromethyl ketone (TLCK), tosyl-L-phenylalanyl chloromethyl ketone (TPCK), kallikrein inactivator (aprotinin), sodiump-hydroxymercuribenzoate (PCMB) and crystallized soybean trypsin inhibitor (STI) were purchased from Calbiochem-Behring Corp., and phenylmethylsulphonyl fluoride (PMSF) and iodoacetamide from Sigma. Sephadex G-200 was from Pharmacia and immobilized soybean trypsin inhibitor from Pierce and Warriner Ltd.
RESULTS
Effect of delayed addithgn of trypsin on plaque formation by Sendai virus
It was essential, for this investigation, to distinguish between Sendai virus that was infective and virus that was non-infective but capable of being activated by trypsin or other protease. Trypsin is required for multiple cycle growth of Sendai virus in MDBK cell cultures, and therefore neither form of virus produced plaques in the absence of trypsin. However, the inclusion of trypsin in the overlay medium resulted in activation of the non-infective virus in the inoculum and so allowed plaque formation by both forms of virus. This difficulty was overcome, as (0) or LLC-MK2 cells (©) and were then overlaid with 5 ml agar medium without trypsin. At the times indicated, 2-5 ml medium containing 8 pg/ml trypsin was added and incubation was continued for a further 4 days. Plaque counts are expressed as a proportion of that obtained with an immediate overlay containing 2 pg/ml trypsin.
Fig. 2. Activation of Sendai virus infectivity by proteases. MK Sendai virus was incubated for 2 h at 36 °C with dilutions of trypsin (O), plasmin (A), subtilisin (A), thermolysin (11) or bromelain ([])
and then titrated for infectivity using a delayed trypsin overlay. Plaque counts are expressed as a proportion of that obtained with untreated virus using an immediate trypsin overlay.
described under Methods, by adding trypsin to the inoculated cultures after a delay of 2 or 3 days; under these conditions, only the infective virus produced plaques. Evidence for this conclusion is provided by the following experiment. Sendai virus grown in eggs (E Sendai, known to be fully infective) or in LLC-MK2 cell cultures (MK Sendai, known to be predominantly non-infective) was assayed for plaqueforming ability in monolayers of MDBK cells. Trypsin was included in the overlay medium of one set of cultures. The medium of other cultures lacked trypsin, but a second overlay containing trypsin was added to these cultures after intervals ranging from 6 h to 4 days. The resulting plaque counts are shown in Fig. 1 . Plaque formation in cultures inoculated with E Sendal was unaffected by an interval as long as 4 days between infection and the addition of trypsin, showing that infective virus could be titrated efficiently with a delayed trypsin overlay. In contrast, plaque counts in cultures inoculated with MK Sendai virus fell rapidly with increasing interval before the addition of trypsin, until with a delay of 2 or more days they became stabilized at a low level. This lower titre represents the small amount of infective virus present in the tissue culture preparation, whereas the titre obtained with an immediate trypsin overlay represents total (infective plus activatable) virus; the difference between the titres represents non-infective but activatable virus, which was unable to enter the cells and presumably underwent thermal degradation before the addition of trypsin.
In preparations of virus from LLC-MK2 cultures, infective virus accounted for only 10 -3 to 10 -4 of the total. Other types of cell culture, e.g. MDBK, Vero, BHK-21 and primary chick embryo, also produced predominantly non-infective virus. However, virus from these cultures was not studied further, since the proportion of infective particles was generally higher than in virus from LLC-MK2 cultures.
Activation of Sendai virus infectivity by trypsin and other proteases
To demonstrate the activation of Sendai virus infectivity, MK Sendai was incubated at 36 °C for 2 h with trypsin at a range of concentrations. Virus infectivities were then titrated as p.f.u./ml using a delayed trypsin overlay. Complete or almost complete activation was achieved by trypsin at concentrations from 0-04 to 1 ~tg/ml (Fig. 2) ; at lower concentrations activation was only partial, and at higher concentrations trypsin inactivated the virus. Porcine plasmin, the bacterial enzymes subtilisin and thermolysin, and the plant thiol protease bromelain also activated Sendai virus (Fig. 2) . With the possible exception of plasmin, all enzymes caused loss of virus infectivity when present in excess, with the result that there was a fairly small range of concentrations over which activation was complete; for bromelain, the difference between activating and inactivating amounts of enzyme was insufficient to allow full virus activation at any concentration.
Activation of Sendai virus infectivity by allantoic fluid
Samples of MK Sendai virus were incubated for 2 h with diluent, with 0-1 ~tg/ml trypsin or with allantoic fluid from a 12-day fertile hen's egg. Infectivities were then assayed using both immediate and delayed trypsin overlays (Table 1) . Treatment with trypsin resulted in full activation; the plaque count with a delayed trypsin overlay increased by 3 log10 units and equalled that seen with an immediate trypsin overlay. Allantoic fluid also produced significant activation, the plaque count with a delayed trypsin overlay rising by 2 log~ 0 units. However, in this and numerous other tests, activation by allantoic fluid was never complete; it was usually about 10 ~o, but sometimes less than 1 ~, of that attainable by trypsin. Moreover, of a total of 90 allantoic fluid samples from individual eggs of various batches, only 48 (53 ~) showed significant activating ability.
Activation of Sendai virus infectivity by amniotic fluid
In contrast to results with allantoic fluid, complete activation of Sendai virus could be achieved by incubation with chick amniotic fluid ( Table 1) . The effect was shown by all eggs at stages of development from 8 days to 14 days. Amniotic fluid from eggs aged 11 or 12 days was chosen for detailed study, since (i) the activity was at least as great as that seen in younger or older eggs, (ii) a good yield of fluid (up to 3 ml) could be obtained at this age, and (iii) at 13 days, the opening of the sero-amniotic connection resulted in the influx of large amounts of albumin into the amniotic cavity. This form of test allowed a quantitative estimate of activating ability. The chosen endpoint was the dilution of activator that produced 10~ activation of infectivity. In this test, the endpoint was achieved by a 1/90 dilution of amniotic fluid and the 'infectivity activation titre' was therefore 90.
Preliminary experiments established that the factor in amniotic fluid responsible for the activation of Sendai virus was non-dialysable and was destroyed by heating at 100 °C for 5 min. These properties, together with others to be described, indicated that the factor was probably an enzyme. It will be referred to as Sendai-activating enzyme or SAE. 
Activation of Sendai virus haemolytic activity by amniotic fluid
Sendai virus grown in LLC-MK2 cells, in contrast to that grown in eggs, did not lyse human red blood cells. Treatment of the virus with trypsin activated its haemolytic ability. A similar effect was produced by treatment with amniotic fluid (Fig. 4) .
Effect of amniotic fluid on polypeptides of Sendai virus
To produce radiolabelled virus, Sendai virus was grown in LLC-MK2 cells as described in Methods, with the difference that the medium consisted of methionine-free Eagle's MEM supplemented with 0"5~o BSA and 130 IICi/ml [35S]methionine. After clarification, aliquots of 1.5 ml were incubated for 1 h at 36 °C with 0.5 ml tenfold concentrated amniotic fluid, with trypsin at 1 ~tg/ml or without added protease. Soybean trypsin inhibitor (2 Ilg/ml) was then added to all samples, the volumes were made up to 5 ml and the suspensions were centrifuged at 35000 rev/min for 1 h; sedimentation of the Sendai virus was aided by the addition of 1 nag purified, unlabelled X31 influenza virus. The virus pellets were resuspended in 0.5 ml saline, dissociated and subjected to SDS-polyacrylamide gel electrophoresis. Autoradiographs (Fig. 5) showed an increase in the amount of F 1 polypeptide after treatment of virus with either trypsin or amniotic fluid. Densitometer tracings indicated that, when standardized against the NP band, the F1 band increased 5.1-fold in virus treated with trypsin and 3.9-fold in virus treated with amniotic fluid. The F2 band was not visible in these autoradiographs.
Requirement of Sendai-activating enzyme for Ca 2+ ions
The diluent normally used in tests for the activation of Sendai virus infectivity contained 2 mm-CaCl2. If calcium was omitted, activation was less efficient, particularly if the amniotic fluid had been dialysed against calcium-free fluid. In one comparison, undialysed amniotic fluid had full activating ability when diluted to 1/25 in the presence of calcium whereas dialysed fluid gave only 4~ activation even when undiluted. The activating ability of dialysed amniotic fluid was restored partially by the addition of 0-2 mM-CaCI2 and fully by 1 mM-CaClz. Further tests indicated that neither Mg 2+ nor Mn z+ ions could be substituted for Ca 2+ ions.
To reduce free Ca 2+ ions to a very low level, tenfold concentrated amniotic fluid was dialysed extensively against 20 mM-Tris HCI pH 7.6 containing 2 mM-EDTA. Activation tests were then carried out with both dialysed and undialysed fluids diluted in medium containing either 2 mM-G. APPLEYARD After concentration, and disruption with 1 ~ SDS and 0.5 ~ 2-mercaptoethanol, the virus was subjected to electrophoresis through a 7.5 to 15 ~ polyacrylamide gel and the polypeptide bands were localized by autoradiography. The major virus-specific proteins are identified. E D T A or 2 mM-CaC12 (Fig. 6 ). The activity of dialysed amniotic fluid was reduced about 300-fold in the absence of Ca z+ ions, but was restored almost to normal by the addition of 2 mMCaC12. The activity of undialysed amniotic fluid in the presence of E D T A did not differ significantly from that of dialysed fluid under the same conditions, indicating the effectiveness of E D T A in removing Ca 2+ ions. To determine whether Ca 2+ ions affected the stability rather than the action of SAE, dilutions of dialysed amniotic fluid were incubated for 2 h at 36 °C in the absence of Ca 2+ ions. CaC12 (2 mM) was then added. This resulted in the complete restoration of activating ability, indicating that Ca 2+ ions were not required for the thermostability of the enzyme over the 2 h period of the usual activation test.
Experiments with dialysed trypsin and dialysed plasmin showed, as expected, that neither of these enzymes required Ca 2+ ions for the activation of Sendal virus infectivity (results not shown). added, the mixtures incubated for a further 2 h and virus infectivities titrated with a delayed trypsin overlay. The activating abilities of both trypsin and amniotic fluid were inhibited by STI, 90~ reduction in activation being achieved by STI concentrations of 1 ~tg/ml and 3 ~g/ml respectively. The dose-response curves were considerably less steep with amniotic fluid than with trypsin, indicating a lower affinity of SAE for the inhibitor. In a further experiment, tenfold concentrated amniotic fluid was diluted 1/10 in normal diluent or in diluent containing STI at 0.25 or 1 I-tg/ml. After 2 h at room temperature, the three samples were assayed for activating ability. Fig. 7 shows that treatment with STI at 0-25 p_g/ml reduced the activity of the amniotic fluid to about one-third of its original value and that treatment with 1 ~tg/ml STI reduced it to about one-ninth. These results allowed an estimate to be made of the approximate concentration of SAE in amniotic fluid (see Discussion).
Effect of soybean trypsin inhibitor on Sendal-activating enzyme
Since SAE was inhibited by STI, it seemed possible that the enzyme might be separated by affinity chromatography on immobilized inhibitor. The results illustrated in Fig. 8 showed that this was the case. The column filtrate and wash fluids contained less than 1 ~o of the added SAE activity, but 70~ of the activity was recovered in the acid eluate. The purified enzyme retained its requirement for Ca 2+ ions (results not shown).
Effect of protease inhibitors on Sendai-activating enzyme
To provide further information on the nature of SAE, a variety of inhibitors were examined for their ability to prevent the activation of Sendai virus by amniotic fluid. Usually, a constant 1/5 or 1/10 dilution of amniotic fluid was held for 1 h at room temperature with a range of concentrations of the compound under test; MK Sendai virus was then added, the mixtures incubated for 2 h at 36 °C and titrated for infective virus. Trypsin at 0.1 or 0.2 txg/ml was treated similarly, and in some tests other proteases were also used. One ml of tenfold concentrated amniotic fluid (infectivity activation titre 690) was applied to a 0.6 ml column of Sepharose-conjugated STI equilibrated with 20 mM-Tris-HC1 pH 7-6, in saline plus 0.1 ~ BSA. The column was washed with 4 ml of the same buffer and 0.1 M-acetic acid plus 0.1 ~ BSA (pH 3) was then added. Effluent fractions of 1 ml were neutralized immediately with NaOH and assayed later for infectivity activation titres. Fig. 9 . Fractionation of amniotic fluid on Sephadex G-200. One ml of tenfold concentrated amniotic fluid (infectivity activation titre 1000, haemolysis activation titre 100), containing blue dextran and phenol red, was applied to a 45 ml column of Sephadex G-200 equilibrated with 20 mM-Tris-HC1 pH 7-6. The column was eluted with the same buffer. Effluent fractions of 1 ml were assayed for infectivity activation (0) and haemolysis activation CA) titres. Arrows mark the peaks of elution of blue dextran (BD) and phenol red (PR). The effects of some inhibitors are summarized in Table 2 . SAE was inhibited by TLCK and aprotinin, although it was considerably less sensitive than trypsin to both of these agents, In tests not included in the Table, plasmin at 10 pg/ml was inhibited 99~ by aprotinin at 10 U/ml and 90~ by TLCK at 1 mM. Like trypsin, SAE was unaffected by TPCK but was inhibited by PMSF. Also like trypsin, it was unaffected by the sulphydryl-blocking agents iodoacetamide and PCMB; under the same conditions, the activity of bromelain (20 ~tg/ml) was inhibited 99 by each of these compounds.
Molecular weight of Sendai-activating enzyme
SAE was non-dialysable and did not pass through a Millipore SM20 membrane. These properties suggested a tool. wt. in excess of 20000.
To obtain a more precise estimate of the mol. wt., tenfold concentrated amniotic fluid was fractionated on Sephadex G-200 (Fig. 9) . Kav values for SAE, determined in three experiments by reference to the elution volumes of blue dextran and phenol red, were 0.37, 0-40 and 0.41 (mean 0.39). Corresponding mean values for ovalbumin, mol. wt. 45000, and bovine serum albumin, mol. wt. 66 000, were 0.44 and 0-35 respectively. These results suggest that the mol. wt. of SAE probably lies between 50000 and 60000.
DISCUSSION
The maturation of both myxoviruses and paramyxoviruses depends upon proteolytic cleavage of an envelope glycoprotein by a host cell enzyme. Cleavage results in a conformational change with exposure of the amino-terminal region of the HA2 peptide of myxoviruses or the F1 peptide of paramyxoviruses; these regions are hydrophobic, closely similar in their amino acid sequences Gething et al., 1978; Ward & Dopheide, 1979; Skehel et al., 1980) , and are involved in the entry of virus into cells (Choppin & Scheid, 1980) . The presence in tissues of an appropriate protease and in virus of a susceptible glycoprotein substrate are essential for the acquisition of virus infectivity. Although either factor can be a major determinant of host range or virus virulence (Nagai et at., 1976; Bosch et al., 1979; Choppin & Scheid, 1980) , most attention has been concentrated recently on the nature of the glycoprotein substrates. Little is known of the host cell protease(s), perhaps because these appear to be predominantly membrane-bound (Lazarowitz et al., 1971 ; Nagai et al., 1976; Silver et al., 1978) and are therefore difficult to study. Evidence for the occurrence of a proteolytic activator in soluble form was first presented by Muramatsu & Homma (1980) . These authors demonstrated a trypsin-like protease, capable of activating the infectivity and haemolytic activity of Sendai virus, in the allantoic fluid of fertile hens' eggs. Our results have both confirmed and extended those observations. Assessment of the activation of Sendai virus infectivity depended upon the use of a delayed trypsin overlay in the plaque assay; this technique enabled infective virus to be titrated in the presence of an excess of potentially infective virus. The method is similar to that described independently by Zhirnov et al. (1982) for influenza virus and should be applicable to the study of the activation of any virus that requires trypsin for plaque development. The activating ability of chick amniotic fluid was found to be at least ten times greater than that of allantoic fluid, and only amniotic fluid was able to activate virus to the same (presumably complete) extent as trypsin. Analysis of virus polypeptides by SDS-polyacrylamide gel electrophoresis indicated that amniotic fluid cleaved the F glycoprotein of Sendai virus in a manner similar to trypsin.
The SAE of amniotic fluid shared with trypsin the ability to be inhibited by ST/, and this interaction was confirmed by the finding that SAE could be separated by affinity chromatography on immobilized inhibitor. The extent of inhibition by STI allows an estimate to be made of the amount of enzyme present in amniotic fluid. Thus, the activity of undiluted amniotic fluid was reduced by two-thirds by treatment with STI (0.25 ~tg/ml) (Fig. 9) . Assuming that one molecule of inhibitor reacts with one molecule of enzyme (Laskowski & Kato, 1980) and that the molecular weights of inhibitor and enzyme are 24000 (Laskowski & Kato, 1980) and 55000 (see Results) respectively, the maximum concentration of SAE is 0-25 x (3/2) x (55 000/24000) = 0.86 ~tg/ml. Since this calculation assumes complete and irreversible binding of inhibitor to enzyme, the concentration is probably overestimated. Assuming a maximum of 1 Ixg enzyme per ml amniotic fluid, the results illustrated in Fig. 3 indicates that, on a molar basis, SAE is more active than trypsin (mol. wt. 24000) for the activation of Sendai virus infectivity. Moreover, unlike trypsin and most other proteases that were tested, SAE did not cause virus inactivation when present in excess.
The susceptibility of SAE to inhibition by PMSF and STI, as well as the similarity of its action to that of trypsin, suggests that the enzyme is a serine protease. However, it differed from typical serine proteases such as trypsin and plasmin in its requirement for Ca 2+ ions. It may be noted that Muramatsu & Homma (1980) reported that the enzyme in allantoic fluid was inhibited by EDTA, although these authors did not identify a metal requirement. The dependence of SAE on G. APPLEYARD AND G. B. DAVIS Ca 2+ ions may account, at least in part, for the variable and relatively poor activating ability of allantoic fluid; dialysis of allantoic fluid to remove urates and phosphates, followed by addition of CaClz, markedly increased its activity although not to the level seen with amniotic fluid (G. Appleyard & G. B. Davis, unpublished observations). Calcium-dependent neutral proteases are found in a variety of tissues (Kubota et al., 1981 ; de Martino, 1981) , but SAE differs from these in its susceptibility to STI and its lack of requirement for sulphydryl groups. There is no evidence that more than one enzyme in amniotic fluid is needed for the activation of Sendai virus. Gel filtration of amniotic fluid gave a single peak of activity measured by the activation of infectivity or haemolytic ability and recovery was approximately 100~. Enzyme purified by affinity chromatography on STI retained its requirement for Ca :+ ions, and again the separation resulted in no significant loss of activity.
In further work, not reported here, we have found that amniotic fluid also activated the infectivity of influenza viruses grown in LLC-MK2 cells. However, the effect was very small compared with that seen with Sendai virus. It seems probable that influenza and Sendai viruses are activated by different host cell enzymes and that only the Sendai-activating enzyme is liberated in significant quantities into amniotic fluid. Possibly several related enzymes are concerned in the activation of different myxo-and paramyxoviruses. The function of these enzymes in the physiology of the host cell is unknown.
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